Obesity and Diabetes: Two Growing Problems this Profitable Pioneer is Helping to Beat
By Malcolm Stacey | Monday 30 October 2023
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Hello Share Twiddlers. Medical pioneering is a laudable investment these days. And with hospital science coming on leaps and bounds, it could also be a profitable one. One company worth a look is Novo Nordisk (0TDD). This is an outfit that tackles the growing problem of obesity. You only have to look around to see how serious that particular situation is.
You must be a registered member to read this story
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.